PubMed HealthSearch

Biomedical subjects

C Timmermans

Publications and source records attributed to C Timmermans.

15 recordsLinked to original sources

Cure of incessant pacemaker circus movement tachycardia by radiofrequency catheter ablation.

INTRODUCTION: Treatment of pacemaker circus movement tachycardia (PCMT) in patients with very long VA conduction times may present a problem. METHODS AND RESULTS: PCMT occurred in a 46-year-old woman with an uncommon AV nodal reentrant tachycardia who developed 2:1 AV block after fast pathway radiofrequency catheter (RF) ablation performed at another institution. Due to the long VA conduction time, PCMT could not be prevented by reprogramming the pacemaker or by the addition of antiarrhythmic drugs. Cure of the PCMT was obtained after selective RF ablation of the slow AV nodal pathway. CONCLUSION: RF ablation of the retrograde conduction offers another alternative for treatment of PCMT.

Catheter Ablation

Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.

OBJECTIVE: To examine the value of programmed electrical stimulation of the heart in predicting sudden death in patients receiving amiodarone to treat ventricular tachyarrhythmias after myocardial infarction. DESIGN: Consecutive patients; retrospective study. SETTING: Referral centre for cardiology, academic hospital. PATIENTS: 106 patients with ventricular tachycardia (n = 77) or ventricular fibrillation (n = 29) late after myocardial infarction. INTERVENTIONS: Programmed electrical stimulation was performed while on amiodarone treatment for at least one month. MEASUREMENTS AND MAIN RESULTS: In 80/106 patients either ventricular fibrillation (n = 15) or sustained monomorphic ventricular tachycardia (n = 65) was induced. After a mean follow up of 50 (SD 40) months (1-144), 11 patients died suddenly and two used their implantable cardioverter debfibrillator. By multivariate analysis two predictors for sudden death were found: (1) inducibility of ventricular fibrillation under amiodarone treatment (P << 0.001), and (2) a left ventricular ejection fraction of < 40% (P < 0.05). The survival rate at one, two, three, and five years was 70%, 62%, 62%, and 40% respectively for patients in whom ventricular fibrillation was induced, and 98%, 96%, 94%, 94% for patients with induced sustained monomorphic ventricular tachycardia. Where there was no sustained arrhythmia, five year survival was 100%. CONCLUSIONS: In patients receiving amiodarone because of life threatening ventricular arrhythmias after myocardial infarction, inducibility of ventricular fibrillation, but not of sustained monomorphic ventricular tachycardia, indicates a high risk of sudden death.

Adult

Aborted sudden death in the Wolff-Parkinson-White syndrome.

In a population of 690 patients with Wolff-Parkinson-White (WPW) syndrome referred to our hospital from January 1979 to February 1995, 15 patients (2.2%) had an aborted sudden death out of the hospital. This retrospective study examines their clinical and electrophysiologic characteristics. Gender, accessory pathway localization, and presence of multiple accessory pathways were compared between patients with and without spontaneous ventricular fibrillation (VF). Whereas gender and the presence of multiple accessory pathways did not significantly differ between both groups, septally located pathways occurred significantly more often in the VF group. In patients with aborted sudden death, spontaneous VF was found significantly more often in men (13 of 15). VF was the first manifestation of the WPW syndrome in 8 patients. The remaining 7 patients had documented episodes of atrial fibrillation, circus movement tachycardia, or both (n = 2). Ten of the 15 patients were exercising or under emotional stress at the time of aborted sudden death. Only 1 patient had 2 accessory pathways. The location of the accessory pathway was septal (midseptal or posteroseptal) in 11 patients, left lateral in 4, and right lateral in 1).

Adolescent

Megalourethra and abnormalities of the cavernous bodies: cause of erectile dysfunction.

Megalourethra is a nonobstructive urethral dilatation associated with poor embryogenic development of the corpus spongiosum and occasionally with maldevelopment of the cavernous bodies. The two entities are distinguished arbitrarily: the scaphoid and the fusiform type. Although megalourethra may be an isolated entity, the association with concomitant upper urinary tract abnormalities is rather frequent. Appropriate investigation of the urinary tract is indicated in all patients presenting this urethral anomaly. We describe the case of a 24-old man complaining of erectile dysfunction due to enlarged corpora cavernosa associated with megalourethra. The penile circumference upon erection made vaginal intromission complicated. Surgical correction based on the Nesbitt technique was performed. The postoperative result is satisfactory and normal sexual life is reported.

Adult

Signal-averaged ECG parameters in cardiac normals using Frank lead system and Fourier transform filter and gender specific differences: a multicenter study.

There is only limited data on normal reference values for signal-averaged electrocardiograms (SAECGs) using Frank leads and fast Fourier transform filter (FFT). Furthermore, the influence of gender on reference values and their relation to body characteristics was only the subject of a few studies on small series of normals. One hundred eighty-five cardiac normals (85 women and 100 men) were examined in this multicenter study. The obtained SAECG values (mean +/- standard deviation) are as follows: filtered QRS duration (FQRSD) = 108.6 +/- 7.5 msec; low amplitude signal duration < 40 microV (LASD) = 30.4 +/- 8.4 msec; and root mean square voltage in the terminal 40 msec (RMSV) = 43.5 +/- 20.6 microV. Between men and women, significant differences were found in FQRSD (111.7 +/- 6.5 vs 105.0 +/- 7.0 msec, P < 0.001) and in RMSV (38.6 +/- 17.4 vs 49.4 +/- 22.7 microV, P < 0.001). No difference was observed for LASD. After normalizing the three SAECG parameters for body characteristics, FQRSD normalized for height was the only variable where gender differences were eliminated. For FQRSD and LASD the 90th percentile and for RMSV the 10th percentile are proposed as cut-off values. Only for the 90th percentile of FQRSD a clear difference between men and women was observed. The following gender specific normal values for SAECG, at 40-Hz high pass filtering, using Frank leads and an FFT filter are proposed: for males, FQRSD < 122 msec; for females, FQRSD < 115 msec; for both genders, LASD < 41 msec and RMSV > 20 microV.

Action Potentials

Supernormal conduction in the left bundle branch.

This report describes a patient with tachycardia-dependent left bundle branch block (LBBB) and atrial extrasystoles, some of which were followed by an unexpectedly narrow QRS complex. His-bundle recordings and premature atrial stimulation were performed to analyze the mechanism underlying the normalized intraventricular conduction of some of the early atrial impulses. The results suggested the presence of supernormal conduction in the left bundle branch (LBB), because: (1) the HV interval was identical in LBBB complexes and in early narrow QRS complexes; (2) during single test stimulation using different paced atrial cycle lengths, there was a well-defined range of H1H2 intervals resulting in normalization of intraventricular conduction; and (3) atrial pacing with a cycle length of 500 msec resulted in alternation between wide and narrow QRS complexes. These findings rule out alternative mechanisms that could explain the unexpectedly normal intraventricular conduction of early impulses.

Bundle-Branch Block

Recurrence rate after accessory pathway ablation.

OBJECTIVE: To evaluate characteristics of patients and accessory pathways as well as additional technical factors involved in the reappearance of accessory pathway conduction after successful ablation. DESIGN: Analysis of recurrences after radiofrequency ablation. SETTING: 163 consecutive patients with 167 accessory pathways. SUBJECTS: 97 men and 66 women with a mean (SD) age of 36 (14) range (11 to 75) years. RESULTS: After a mean (SD) follow up of 14 (7) range (2 to 27) months, conduction recurred in 13 out of 167 (7.8%) accessory pathways. The initial manifestation of recurrence was circus movement tachycardia in 7 patients and reappearance of delta waves on a 12 lead electrocardiogram in 6 patients. The interval to the return of accessory pathway conduction ranged from 3 hours to 90 days. Age, sex, presence of multiple accessory pathways, criteria to determine the target ablation site, number and duration of radiofrequency applications, and cumulative energy did not significantly differ between the groups with recurrence and without. Recurrence was less common with concealed accessory pathways (2/44) than with overt accessory pathways (11/110). The difference was not significant. The only variable to influence the recurrences in this study group was the location of the accessory pathway. Reappearance of conduction through right sided accessory pathways occurred significantly more often than through left sided ones (8/40 v 5/114, P = 0.01). CONCLUSION: After radiofrequency ablation the recurrence rate of accessory pathways is low and there are no predictors of the risk of reappearance of conduction apart from the right sided location of the accessory pathway.

Adolescent

Platypnoea syndrome caused by atrial septal aneurysm.

A patient with platypnoea after right pneumonectomy and radiotherapy is described. On transoesophageal contrast echocardiography and cardiac catheterization, an atrial septal aneurysm with interatrial right-to-left shunting was detected. Symptoms disappeared after surgical correction. To the best of our knowledge, this is the first report of a patient with a septal aneurysm and severe platypnoea.

Aged

Platypnea-orthodeoxia syndrome: a report of two cases.

Two cases of orthostatic dyspnea and arterial desoxygenation, as a postpneumonectomy complication, are reported. In one patient, echocardiography and cardiac catheterization revealed the presence of an atrial septal aneurysm, which has never been described in association with the platypnea-orthodeoxia syndrome. The other case illustrates that, despite actual technical possibilities, clinical suspicion remains a prerequisite for proper diagnosis of the entity.

Aged

Ridogrel in the setting of percutaneous transluminal coronary angioplasty.

The safety of the combination of heparin and ridogrel therapy and its antiplatelet efficacy was examined in the setting of percutaneous transluminal coronary angioplasty (PTCA). In 32 patients without known aspirin intake for 10 days before PTCA, therapy with ridogrel (300-mg intravenous bolus) was begun just before PTCA and continued orally at a dose of 300 mg twice daily until discharge. Heparin was administered as a 10,000 IU bolus dose before PTCA and followed by an intravenous infusion at a rate of 1,000 IU/hour for 24 hours. Bleeding problems at the arterial entry site occurred in 13 patients, which required a blood transfusion in only 2 patients. One patient underwent emergency bypass surgery without specific problems of hemostasis. Ridogrel virtually eliminated thromboxane B2 from the serum (29,990 +/- 6,555 pg/0.1 ml before vs 63 +/- 7 pg/0.1 ml at 2 hours after ridogrel), with a concomitant increase in serum 6-keto-prostaglandin F1 alpha (511 +/- 34 pg/0.1 ml before vs 1,190 +/- 146 pg/0.1 ml at 24 hours after ridogrel). There were no acute reocclusions in the ridogrel-treated patients, whereas acute reocclusions occurred in 5.6% of the patients taking the standard aspirin + heparin regimen during the same period. Furthermore, at 6-month clinical follow-up patients treated with ridogrel compared favorably with those receiving standard treatment.

6-Ketoprostaglandin F1 alpha

Diagnostic value of transesophageal echocardiography in platypnea.

Platypnea is a rare syndrome of orthostatic dyspnea frequently caused by an interatrial right-to-left shunt. The diagnosis is difficult. Assessment of arterial blood gases reveals orthostatic desaturation. In the past, definite diagnosis necessitated catheterization in the supine and upright position. Now transesophageal echocardiography on a tilt table combined with a peripheral venous contrast study provides correct diagnosis in a safe and easy way.

Aged

Assessment of the optimal atrioventricular delay in dual chamber-paced patients by a portable scintillation probe (VEST).

BACKGROUND: The optimal atrioventricular delay in dual-chamber pacing differs from patient to patient. The availability of a portable scintillation probe (VEST) enables noninvasive monitoring of left ventricular function. METHODS AND RESULTS: Hemodynamic variations were measured in 10 patients with programmable DDD pacemakers. The ejection fraction, stroke volume, and diastolic and systolic volume were evaluated, programming six different atrioventricular delays ranging from 75 to 200 msec, to determine the most favorable atrioventricular delay. Comparing left ventricular ejection fraction (LVEF), stroke volume, and end-diastolic and end-systolic volume at each DVI mode with a preceding DVI setting of 75 msec, all parameters at 200 msec were statistically different from those at 100 msec. An increase of LVEF and stroke volume and a decrease of end-systolic volume was found. In only five patients a switch of VVI mode to the optimal DVI mode results in an increase of LVEF of more than 5%. CONCLUSIONS: Our study stresses the importance of optimizing atrioventricular delay. The VEST system permits these measurements, increasing the accuracy of the determination of optimal atrioventricular delay, and appears to be valuable in the management of patients with cardiac dual-chamber pacemakers.

Aged